Overall, these findings suggest DDX11-AS1 as a key EMT-related lncRNA in ESCC progression and a potential therapeutic target, working through miR-30d-5p to regulate SNAI1/ZEB2 and the Wnt/β-catenin pathway. Here, ZEB2 is linked to esophageal squamous cell carcinoma.